Shandong Jincheng Pharmaceutical Group Co., Ltd

XSEC:300233 Stock Report

Market Cap: CN¥4.9b

Shandong Jincheng Pharmaceutical Group Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jiaquan Li

Chief executive officer

CN¥1.8m

Total compensation

CEO salary percentagen/a
CEO tenure13.8yrs
CEO ownership0.3%
Management average tenure1.9yrs
Board average tenure4.6yrs

Recent management updates

Recent updates


CEO

Jiaquan Li (52 yo)

13.8yrs

Tenure

CN¥1,799,000

Compensation

Mr. Jiaquan Li serves as Vice Chairman at Shandong Jincheng Pharmaceutical Group Co., Ltd. He has been Director at Shandong Jincheng Pharmaceutical Group Co., Ltd. since May 16, 2011 and also serves as its...


Leadership Team

NamePositionTenureCompensationOwnership
Jiaquan Li
President & Vice Chairmanno dataCN¥1.80m0.27%
CN¥ 13.3m
Jing Liu
Financial Director1.7yrsCN¥677.00kno data
Xiaogang Zhu
VP & Secretary of the Board of Directors13.8yrsCN¥995.00k0.085%
CN¥ 4.2m
Xi Li Cui
VP & Directorno dataCN¥1.20m0.047%
CN¥ 2.3m
Zhongzheng Zhang
Vice President1.9yrsCN¥1.19m0.014%
CN¥ 697.9k

1.9yrs

Average Tenure

48yo

Average Age

Experienced Management: 300233's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Jiaquan Li
President & Vice Chairman13.8yrsCN¥1.80m0.27%
CN¥ 13.3m
Xi Li Cui
VP & Directorno dataCN¥1.20m0.047%
CN¥ 2.3m
Yeqing Zhao
Chairman13.8yrsCN¥2.00m1.91%
CN¥ 93.4m
Fanqing Meng
Employee Representative of the Supervisory Board10.8yrsno datano data
Xinyu Wang
Independent Director4.6yrsCN¥77.90kno data
Qixiao Cai
Independent Director4.6yrsCN¥77.90kno data
Qingye Li
Chairman of the Supervisory Board4.6yrsno datano data
Fuli Li
Independent Director1.7yrsCN¥60.00kno data
Qinyuan Ma
Non-Independent Director1.7yrsCN¥337.00k0.0047%
CN¥ 232.8k
Chao Wang
Supervisor1.7yrsno datano data

4.6yrs

Average Tenure

48.5yo

Average Age

Experienced Board: 300233's board of directors are considered experienced (4.6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 13:57
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shandong Jincheng Pharmaceutical Group Co., Ltd is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yalei YanBohai Securities Co., Ltd.
YANG QIAOChangjiang Securities Co. LTD.
Chong ChenFounder Securities Co., Ltd.